Inventor · Cherry Hill, NJ, US

Michael C. Milone

45Patents
17h-index
62Co-inventors
80Inventor score

Filing activity: Dec 9, 2011 → Jun 25, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8906682B2 Methods for treatment of cancer Chemistry; Metallurgy 299 Active
US8911993B2 Compositions for treatment of cancer Chemistry; Metallurgy 230 Active
US8916381B1 Methods for treatment of cancer Chemistry; Metallurgy 178 Active
US9101584B2 Methods for treatment of cancer Chemistry; Metallurgy 165 Active
US9102761B2 Compositions for treatment of cancer Chemistry; Metallurgy 165 Active
US9102760B2 Compositions for treatment of cancer Chemistry; Metallurgy 165 Active
US8975071B1 Compositions for treatment of cancer Chemistry; Metallurgy 163 Active
US9499629B2 Use of chimeric antigen receptor-modified T-cells to treat cancer Chemistry; Metallurgy 116 Active
US9464140B2 Compositions and methods for treatment of cancer Chemistry; Metallurgy 97 Active
US9745368B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 95 Active
US9540445B2 Compositions and methods for treatment of cancer Chemistry; Metallurgy 81 Active
US9481728B2 Compositions and methods for treatment of cancer Chemistry; Metallurgy 81 Active
US9815901B2 Treatment of cancer using a CD123 chimeric antigen receptor Chemistry; Metallurgy 80 Active
US9328156B2 Use of chimeric antigen receptor-modified T cells to treat cancer Chemistry; Metallurgy 78 Active
US9518123B2 Compositions and methods for treatment of cancer Chemistry; Metallurgy 76 Active
US10174095B2 Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 27 Active
US10287354B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 21 Active
US10273300B2 Methods of making chimeric antigen receptor-expressing cells Chemistry; Metallurgy 14 Active
US11084880B2 Anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 8 Active
US10301370B2 Compositions and methods of chimeric autoantibody receptor T cells Chemistry; Metallurgy 4 Active
US10577417B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 4 Active
US10829735B2 Methods for improving the efficacy and expansion of immune cells Chemistry; Metallurgy 4 Active
US10851149B2 Treatment of cancer using GFR α-4 chimeric antigen receptor Chemistry; Metallurgy 2 Active
US10738099B2 Method of redirecting T cells to treat HIV infection Chemistry; Metallurgy 1 Active
US10640553B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.